Tesetaxel: Phase I started

Genta began an open-label, U.S. Phase II trial in up to 55 patients to evaluate 40 mg oral tesetaxel once every 3 weeks or 50 mg oral tesetaxel weekly for 3 consecutive weeks. Tesetaxel has Orphan Dru...